BROOKE W ROSENBERG

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant WINSTON SALEM, NC NPI 1235367152

General Payments — all program years on this page

$1,173.59

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $386.46 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $386.4620

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $167.577
PFIZER INC. $125.647
NOVARTIS PHARMACEUTICALS CORPORATION $93.256

By program year

Program yearAmountRecords
2021 $213.4514
2022 $352.1922
2023 $221.4913
2024 $386.4620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087169331 Novartis Pharmaceuticals Corporation $14.60 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087169333 Novartis Pharmaceuticals Corporation $14.31 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087169335 Novartis Pharmaceuticals Corporation $16.18 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087169337 Novartis Pharmaceuticals Corporation $16.57 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087169339 Novartis Pharmaceuticals Corporation $14.55 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087169341 Novartis Pharmaceuticals Corporation $17.04 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113976 ABBVIE INC. $27.04 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113978 ABBVIE INC. $27.43 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113980 ABBVIE INC. $16.44 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113982 ABBVIE INC. $23.49 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113984 ABBVIE INC. $24.87 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113986 ABBVIE INC. $21.55 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108113988 ABBVIE INC. $26.75 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131652345 PFIZER INC. $18.77 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131652656 PFIZER INC. $19.25 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131655513 PFIZER INC. $16.02 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131655828 PFIZER INC. $19.60 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131657507 PFIZER INC. $17.00 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131658530 PFIZER INC. $17.97 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131658598 PFIZER INC. $17.03 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.